Auro Laboratories Limited announced that the Board of Directors of the Company, at their meeting held on August 23, 2023, have approved a capacity expansion in the existing unit of the Company. Particulars, Details, Existing Capacity, Metformin HCL - 1800 MT /P. A, Existing capacity Utilisation, Metformin HCL- 1200 MT /P. A., Proposed Capacity Utilisation, Metform in HCL - 3600 MT /P. A., Period within which the proposed Capacity is to be added, 31st March 2024, Investment required, 40.00 cr. Approx., Mode of Financing, Internal Accruals and Term Loan from Bank, Rationale, The product Metformin HCL is expected to have significant demand in the near future with a growth rate of over 10% worldwide in Type 2 Diabetes disease.